選択的アンドロゲン受容体修飾薬
参考資料

↑  “Pharmacodynamics of selective androgen receptor modulators”. The Journal of Pharmacology and Experimental Therapeutics 304 (3):  1334–40. (March 2003). doi:10.1124/jpet.102.040840. PMC 2040238. PMID 12604714. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040238/.
↑  “Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis”. Biological & Pharmaceutical Bulletin 26 (11):  1563–9. (November 2003). doi:10.1248/bpb.26.1563. PMID 14600402.
↑  “Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats”. Endocrinology 148 (1):  4–12. (January 2007). doi:10.1210/en.2006-0843. PMID 17008401.
↑  Aethyta (2015-10-19), English: Structure of RAD140., https://commons.wikimedia.org/wiki/File:RAD140_structure.png 2017年9月21日閲覧。
↑  “Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators”. Bioorganic & Medicinal Chemistry Letters 17 (16):  4487–90. (August 2007). doi:10.1016/j.bmcl.2007.06.007. PMID 17574413.
↑  “Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators”. Journal of Medicinal Chemistry 50 (16):  3857–69. (August 2007). doi:10.1021/jm0613976. PMID 17636947.
↑  “Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity”. Bioorganic & Medicinal Chemistry Letters 18 (9):  2967–71. (May 2008). doi:10.1016/j.bmcl.2008.03.062. PMID 18400499.
↑  “Selective androgen receptor modulators--prospects for emerging therapy in osteoporosis?”. Journal of Musculoskeletal & Neuronal Interactions 5 (4):  355. (2005). PMID 16340136. http://www.ismni.org/jmni/pdf/22/23THOMPSON.pdf.
↑  “SARM for women”. (2020年).  オリジナルの2020年6月10日時点におけるアーカイブ。. https://web.archive.org/web/20201006100729/https://bodybuildingmatrix.com/sarms-for-women/
↑  “Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium”. The Journal of Clinical Endocrinology and Metabolism 84 (10):  3459–62. (October 1999). doi:10.1210/jc.84.10.3459. PMID 10522980.
↑  M.S. Steiner (June 2010). “Effect of GTx-024, a selective androgen receptor modulator (SARM), on stair climb and quality of life (QOL) in patients with cancer cachexia”. J Clin Oncol 28 (1534). doi:10.1200/jco.2010.28.15_suppl.9147. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=74&abstractID=52947.
↑  “Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator”. The Journal of Steroid Biochemistry and Molecular Biology 109 (1–2):  129–37. (March 2008). doi:10.1016/j.jsbmb.2007.11.001. PMID 18164613.
↑  “Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator”. The Journal of Pharmacology and Experimental Therapeutics 328 (2):  663–70. (February 2009). doi:10.1124/jpet.108.146811. PMID 19017848.
↑  “Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception”. Endocrinology 150 (1):  385–95. (January 2009). doi:10.1210/en.2008-0674. PMC 2630904. PMID 18772237. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630904/.
↑  “Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140”. ACS Medicinal Chemistry Letters 2 (2):  124–9. (February 2011). doi:10.1021/ml1002508. PMC 4018048. PMID 24900290. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018048/.
↑  “Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor”. The Journal of Pharmacology and Experimental Therapeutics 304 (3):  1323–33. (March 2003). doi:10.1124/jpet.102.040832. PMID 12604713.
↑  “Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats”. Pharmaceutical Research 24 (2):  328–35. (February 2007). doi:10.1007/s11095-006-9152-9. PMC 2039878. PMID 17063395. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039878/.
↑  “Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)”. Journal of Medicinal Chemistry 42 (2):  210–2. (January 1999). doi:10.1021/jm9806648. PMID 9925725.
↑  “Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands”. Pharmaceutical Research 23 (8):  1641–58. (August 2006). doi:10.1007/s11095-006-9024-3. PMC 2072875. PMID 16841196. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072875/.
テストステロンの構造式
RAD140（英語版）の構造式
エノボサームの構造式